Italia markets closed

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
1,7000-0,1000 (-5,56%)
Alla chiusura: 04:00PM EDT
1,7000 0,00 (0,00%)
Dopo ore: 07:56PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente1,8000
Aperto1,8000
Denaro1,7000 x 38800
Lettera1,7400 x 38800
Min-Max giorno1,6900 - 1,8000
Intervallo di 52 settimane1,6900 - 8,5800
Volume12.112.254
Media Volume6.909.288
Capitalizzazione811,993M
Beta (5 anni mensile)1,95
Rapporto PE (ttm)N/D
EPS (ttm)-1,4060
Prossima data utili07 nov 2022 - 11 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A3,58
  • GlobeNewswire

    Clover Health to Present at 2022 Wells Fargo Healthcare Conference on September 7, 2022

    FRANKLIN, Tenn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 9:10 a.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at htt

  • GlobeNewswire

    Clover Health Reports Second Quarter 2022 Financial Results

    Second quarter total revenue was $846.7 million compared to $412.5 million in second quarter 2021 Lives under Clover Management grew to ~255,000 from ~129,000 year-over-year Second quarter Insurance (Medicare Advantage) Medical Care Ratio ("MCR") of 92.1% shows significant improvement year-over-year FRANKLIN, Tenn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to improving

  • GlobeNewswire

    Clover Health Announces Evolution of Leadership Roles to Best Support Future Growth

    Vivek Garipalli to transition the role of CEO to Co-Founder and President Andrew Toy effective January 1, 2023; Mr. Garipalli to continue with Clover as Executive Chairperson moving forwardFRANKLIN, Tenn., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”) today announced that Vivek Garipalli, its founder and current Chief Executive Officer (“CEO”) and Chairperson, will transition his role of CEO to Co-Founder and President Andrew Toy,